PLEASANTON, Calif., Feb. 1, 2012 (GLOBE NEWSWIRE) -- ZELTIQ® Aesthetics, Inc. (Nasdaq:ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, announced today that Gordie Nye, Chief Executive Officer, is scheduled to present at the Leerink Swann 2012 Global Healthcare Conference in New York City.
Event: Leerink Swann 2012 Global Healthcare Conference
Date: Thursday, February 16, 2012
Time: 8 a.m. ET
An audio webcast of the Company's presentation will be available by visiting the investor relations section of ZELTIQ's website at www.coolsculpting.com. A replay of the presentation will be available for 30 days.
About ZELTIQ Aesthetics
ZELTIQ Aesthetics is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. The Company's first commercial product, the CoolSculpting System, is designed to selectively reduce stubborn fat bulges that may not respond to diet or exercise. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. CoolSculpting utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis, without causing scar tissue or damage to the skin, nerves, or surrounding tissues. ZELTIQ developed CoolSculpting to safely, noticeably, and measurably reduce the fat layer within a treated fat bulge without requiring the patient to diet or exercise.